<DOC>
	<DOCNO>NCT01764035</DOCNO>
	<brief_summary>The investigator propose investigate efficacy brief ( 4-session ) Body Scan ( BS ) meditation intervention individual bipolar I disorder insomnia ( i.e . difficulty fall stay asleep ) . The investigator compare Body Scan intervention 4-session brief supportive psychotherapy ( SP ) intervention . The investigator hypothesize Body Scan improve objective sleep quantity quality .</brief_summary>
	<brief_title>Mindfulness Therapy Disrupted Sleep Bipolar Disorder</brief_title>
	<detailed_description>This first evaluation efficacy mindfulness-based intervention insomnia bipolar disorder . It distill finding previous mindfulness-based intervention disorder document beneficial effect sleep , concentrate active mindfulness ingredient treat sleep ( Body Scan ) . To date , mindfulness base study focus either subjective sleep report laboratory-based measure sleep , long call question lack ecological validity . This study take advantage recent development ambulatory sleep monitoring use new , FDA approve M1 device , assess sleep objectively patient 's home environment . The M1 device also ambulatory sleep-monitoring device date simultaneously assess sleep quantity quality . Finally , study broadens view beyond sleep mood investigates impact cognitive sleep-related psychosocial functioning , end treatment well 3-month follow-up . Overall , work could result brief , easy administer , easy disseminate intervention patient bipolar disorder insomnia .</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Bipolar Disorder</mesh_term>
	<mesh_term>Sleep Initiation Maintenance Disorders</mesh_term>
	<mesh_term>Dyssomnias</mesh_term>
	<mesh_term>Sleep Wake Disorders</mesh_term>
	<mesh_term>Parasomnias</mesh_term>
	<mesh_term>Disorders Excessive Somnolence</mesh_term>
	<criteria>Men woman age 1865 DSMIV diagnosis bipolar I II disorder HAMD17 score &lt; 17 ( i.e . low depressive symptom ) YMRS score &lt; 8 ( i.e . low manic symptom ) Optimized , stable maintenance pharmacotherapy maximum tolerate dosage accordance revise Texas Implementation Medication Algorithm DSMIV insomnia A B criterion meet ( i.e . difficulty initiate maintain sleep , least 1 month ) operationally define : 1 . Insomnia Severity Index score &gt; 15 ( moderate clinical insomnia ) 2 . M1 derive average actigraphic total sleep time &lt; 6 hour , &lt; 40 % average total sleep time high frequency coupling , measure M1 device 5 day prerandomization , correspond &lt; 1SD mean M1 normative comparison sample healthy control participant . DSMIV bipolar I disorder subtype rapid cycling DSMIV manic mixed episode past 2 month DSMIV major depressive episode past 2 month Psychotropic medication accordance revise Texas Implementation Medication Algorithm Pregnancy Medical illness nonpsychiatric medical treatment likely cause sleep disturbance interferes study participation Neurologic disorder , previous ECT , history head trauma ( i.e . know structural brain lesion ) Current past history select DSMIV Axis I disorder bipolar disorder include : organic mental disorder , substance abuse within past 12 month and/or history substance abuse &gt; 1 year ; past current substance dependence ( include alcohol ) , schizophrenia , delusional disorder , psychotic disorder otherwise specify Axis I disorder need primary focus treatment ( e.g . current DSMIV anxiety disorder disrupts sleep ) Sleep apnea , restless leg syndrome , narcolepsy Concurrent psychotherapy BS SP .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>June 2016</verification_date>
	<keyword>Psychotherapy</keyword>
	<keyword>Bipolar Disorder</keyword>
	<keyword>Sleep Problems</keyword>
	<keyword>Insomnia</keyword>
	<keyword>Hypersomnia</keyword>
	<keyword>Mindfulness</keyword>
	<keyword>Meditation</keyword>
	<keyword>Sleep Disturbance</keyword>
</DOC>